5Lonergan PE, Tindall DJ. Androgen receptor signaling in prostate cancer development and progression[J]. J Car- einog, 2011,10:20.
6Li R, Wheeler T, Dai H, et al. High level o5 androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free surviv- al in prostate., cancer patients treated with radical prosta- tectomy[J]. Am J Surg Pathol, 2004, 28(7) :928-934.
7Coffey K, Robson CN. Regulation of the androgen recep- tor by post-translational modifieations[J]. J Endocrinol, 2012, 215(2) :221-237.
8Voutsadakis IA, Papandreou CN. The ubiquitin-protea- some system in prostate cancer and its transition to cas- tration resistance[J]. Urol Oneol, 2012, 30(6):752-761.
9Koochekpour S, Yujun zhang, Beroukhim R, etal. Am- plification and overexpression of prosaposin in prostate Cancer[J]. Genes Chromosome & Cancer, 2005, 44(4) : 351 - 364.
10Lee TJ, Sartor O, Luftig RB, etal. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells [J]. Molecular Cancer, 2004, 3: 31.
